ID   INO1_HUMAN              Reviewed;         558 AA.
AC   Q9NPH2; B3KRT1; G5E9U0; Q6NXT5; Q7Z525; Q9BT65; Q9H2Y2; Q9NSU0;
AC   Q9NVW7;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 139.
DE   RecName: Full=Inositol-3-phosphate synthase 1;
DE            Short=IPS 1;
DE            EC=5.5.1.4;
DE   AltName: Full=Myo-inositol 1-phosphate synthase;
DE            Short=MI-1-P synthase;
DE            Short=MIP synthase;
DE            Short=hIPS;
DE   AltName: Full=Myo-inositol 1-phosphate synthase A1;
DE            Short=hINO1;
GN   Name=ISYNA1; Synonyms=INO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Hepatoma;
RX   PubMed=12941308; DOI=10.1016/S0003-9861(03)00388-6;
RA   Guan G., Dai P., Shechter I.;
RT   "cDNA cloning and gene expression analysis of human myo-inositol 1-
RT   phosphate synthase.";
RL   Arch. Biochem. Biophys. 417:251-259(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=17121280;
RA   Parthasarathy L.K., Seelan R.S., Tobias C., Casanova M.F.,
RA   Parthasarathy R.N.;
RT   "Mammalian inositol 3-phosphate synthase: its role in the biosynthesis
RT   of brain inositol and its clinical use as a psychoactive agent.";
RL   Subcell. Biochem. 39:293-314(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zhou Y., Yu L., Zhao E.P., Hua Y.M., Xin Y.R., Zhao S.Y.;
RT   "Cloning of a novel human cDNA homology to S.polyrrhiza D-myo-
RT   inositol-3-phosphate synthase mRNA.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Embryo, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INDUCTION.
RX   PubMed=15464731; DOI=10.1016/j.abb.2004.08.002;
RA   Seelan R.S., Parthasarathy L.K., Parthasarathy R.N.;
RT   "E2F1 regulation of the human myo-inositol 1-phosphate synthase
RT   (ISYNA1) gene promoter.";
RL   Arch. Biochem. Biophys. 431:95-106(2004).
RN   [10]
RP   FUNCTION, ENZYME ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=15024000; DOI=10.1074/jbc.M312078200;
RA   Ju S., Shaltiel G., Shamir A., Agam G., Greenberg M.L.;
RT   "Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast.";
RL   J. Biol. Chem. 279:21759-21765(2004).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=17988368; DOI=10.1111/j.1399-5618.2007.00440.x;
RA   Shamir A., Shaltiel G., Mark S., Bersudsky Y., Belmaker R.H., Agam G.;
RT   "Human MIP synthase splice variants in bipolar disorder.";
RL   Bipolar Disord. 9:766-771(2007).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=17901568;
RA   Galit S., Shirley M., Ora K., Belmaker R.H., Galila A.;
RT   "Effects of valproate derivatives on human brain myo-inositol-1-
RT   phosphate (MIP) synthase activity and amphetamine-induced rearing.";
RL   Pharmacol. Rep. 59:402-407(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Key enzyme in myo-inositol biosynthesis pathway that
CC       catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol
CC       1-phosphate in a NAD-dependent manner. Rate-limiting enzyme in the
CC       synthesis of all inositol-containing compounds.
CC       {ECO:0000269|PubMed:15024000}.
CC   -!- CATALYTIC ACTIVITY: D-glucose 6-phosphate = 1D-myo-inositol 3-
CC       phosphate. {ECO:0000269|PubMed:15024000}.
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:15024000};
CC   -!- ENZYME REGULATION: Inhibited by mood-stabilizing drugs such as
CC       valproate (VPA) and lithium. {ECO:0000269|PubMed:17901568,
CC       ECO:0000269|PubMed:17988368}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.57 mM for 6-phosphate {ECO:0000269|PubMed:15024000};
CC         KM=8 uM for NAD {ECO:0000269|PubMed:15024000};
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:15024000};
CC   -!- PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-
CC       inositol from D-glucose 6-phosphate: step 1/2.
CC   -!- INTERACTION:
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-720563, EBI-752420;
CC       Q9BUZ4:TRAF4; NbExp=6; IntAct=EBI-720563, EBI-3650647;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NPH2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NPH2-2; Sequence=VSP_032324;
CC       Name=3;
CC         IsoId=Q9NPH2-3; Sequence=VSP_046065;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, ovary, heart,
CC       placenta and pancreas. Weakly expressed in blood leukocyte,
CC       thymus, skeletal muscle and colon. {ECO:0000269|PubMed:12941308}.
CC   -!- INDUCTION: By glucose and lovastain. Up-regulation is prevented by
CC       mevalonic acid, farnesol, and geranylgeraniol. Up-regulated by
CC       E2F1. {ECO:0000269|PubMed:12941308, ECO:0000269|PubMed:15464731}.
CC   -!- SIMILARITY: Belongs to the myo-inositol 1-phosphate synthase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP97151.1; Type=Frameshift; Positions=82, 85, 496; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF207640; AAG35698.1; -; mRNA.
DR   EMBL; AF220530; AAF26444.1; -; mRNA.
DR   EMBL; AF220259; AAF26739.1; -; Genomic_DNA.
DR   EMBL; AF220250; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220251; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220252; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220253; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220254; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220255; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220256; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220257; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF220258; AAF26739.1; JOINED; Genomic_DNA.
DR   EMBL; AF086921; AAP97151.1; ALT_FRAME; mRNA.
DR   EMBL; AK001325; BAA91626.1; -; mRNA.
DR   EMBL; AK021526; BAB13837.1; -; mRNA.
DR   EMBL; AK092179; BAG52493.1; -; mRNA.
DR   EMBL; AL137749; CAB70904.1; -; mRNA.
DR   EMBL; AC008397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84703.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84705.1; -; Genomic_DNA.
DR   EMBL; BC004320; AAH04320.1; -; mRNA.
DR   EMBL; BC018952; AAH18952.1; -; mRNA.
DR   EMBL; BC066902; AAH66902.1; -; mRNA.
DR   CCDS; CCDS12379.1; -. [Q9NPH2-1]
DR   CCDS; CCDS54234.1; -. [Q9NPH2-3]
DR   CCDS; CCDS62603.1; -. [Q9NPH2-2]
DR   PIR; T46317; T46317.
DR   RefSeq; NP_001164409.1; NM_001170938.1. [Q9NPH2-3]
DR   RefSeq; NP_001240318.1; NM_001253389.1. [Q9NPH2-2]
DR   RefSeq; NP_057452.1; NM_016368.4. [Q9NPH2-1]
DR   UniGene; Hs.405873; -.
DR   ProteinModelPortal; Q9NPH2; -.
DR   SMR; Q9NPH2; -.
DR   BioGrid; 119562; 34.
DR   IntAct; Q9NPH2; 7.
DR   MINT; MINT-4942504; -.
DR   STRING; 9606.ENSP00000337746; -.
DR   DrugBank; DB01840; 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate.
DR   DrugBank; DB04516; 2-Deoxy-Glucitol-6-Phosphate.
DR   DrugBank; DB04077; Glycerol.
DR   iPTMnet; Q9NPH2; -.
DR   PhosphoSitePlus; Q9NPH2; -.
DR   BioMuta; ISYNA1; -.
DR   DMDM; 74734304; -.
DR   REPRODUCTION-2DPAGE; IPI00549569; -.
DR   EPD; Q9NPH2; -.
DR   MaxQB; Q9NPH2; -.
DR   PaxDb; Q9NPH2; -.
DR   PeptideAtlas; Q9NPH2; -.
DR   PRIDE; Q9NPH2; -.
DR   DNASU; 51477; -.
DR   Ensembl; ENST00000338128; ENSP00000337746; ENSG00000105655. [Q9NPH2-1]
DR   Ensembl; ENST00000457269; ENSP00000415458; ENSG00000105655. [Q9NPH2-3]
DR   Ensembl; ENST00000578963; ENSP00000475677; ENSG00000105655. [Q9NPH2-2]
DR   GeneID; 51477; -.
DR   KEGG; hsa:51477; -.
DR   UCSC; uc002nja.3; human. [Q9NPH2-1]
DR   CTD; 51477; -.
DR   DisGeNET; 51477; -.
DR   GeneCards; ISYNA1; -.
DR   HGNC; HGNC:29821; ISYNA1.
DR   HPA; CAB020720; -.
DR   HPA; HPA007931; -.
DR   HPA; HPA008232; -.
DR   MalaCards; ISYNA1; -.
DR   MIM; 611670; gene.
DR   neXtProt; NX_Q9NPH2; -.
DR   OpenTargets; ENSG00000105655; -.
DR   PharmGKB; PA164721116; -.
DR   eggNOG; KOG0693; Eukaryota.
DR   eggNOG; COG1260; LUCA.
DR   GeneTree; ENSGT00390000018395; -.
DR   HOGENOM; HOG000013469; -.
DR   HOVERGEN; HBG061200; -.
DR   InParanoid; Q9NPH2; -.
DR   KO; K01858; -.
DR   OMA; NPVLYAP; -.
DR   OrthoDB; EOG091G05DF; -.
DR   PhylomeDB; Q9NPH2; -.
DR   TreeFam; TF300382; -.
DR   Reactome; R-HSA-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   UniPathway; UPA00823; UER00787.
DR   ChiTaRS; ISYNA1; human.
DR   GenomeRNAi; 51477; -.
DR   PRO; PR:Q9NPH2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105655; -.
DR   CleanEx; HS_ISYNA1; -.
DR   ExpressionAtlas; Q9NPH2; baseline and differential.
DR   Genevisible; Q9NPH2; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004512; F:inositol-3-phosphate synthase activity; IMP:CACAO.
DR   GO; GO:0006021; P:inositol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR002587; Myo-inos-1-P_Synthase.
DR   InterPro; IPR013021; Myo-inos-1-P_Synthase_GAPDH.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR11510; PTHR11510; 1.
DR   Pfam; PF01658; Inos-1-P_synth; 1.
DR   Pfam; PF07994; NAD_binding_5; 1.
DR   PIRSF; PIRSF015578; Myoinos-ppht_syn; 1.
DR   SUPFAM; SSF51735; SSF51735; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Inositol biosynthesis; Isomerase; Lipid biosynthesis;
KW   Lipid metabolism; NAD; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome.
FT   CHAIN         1    558       Inositol-3-phosphate synthase 1.
FT                                /FTId=PRO_0000324628.
FT   VAR_SEQ       1    128       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_032324.
FT   VAR_SEQ      40     93       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046065.
FT   CONFLICT     17     17       G -> S (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT     35     35       E -> K (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT     57     57       P -> T (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT     82     82       R -> Q (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT     91     91       Missing (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT    155    155       K -> N (in Ref. 1; AAG35698).
FT                                {ECO:0000305}.
FT   CONFLICT    193    193       D -> N (in Ref. 3; AAP97151).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       P -> Q (in Ref. 8; AAH66902).
FT                                {ECO:0000305}.
FT   CONFLICT    392    392       S -> G (in Ref. 8; AAH66902).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       H -> R (in Ref. 4; BAG52493).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       P -> R (in Ref. 8; AAH66902).
FT                                {ECO:0000305}.
FT   CONFLICT    514    514       S -> C (in Ref. 4; BAA91626).
FT                                {ECO:0000305}.
SQ   SEQUENCE   558 AA;  61068 MW;  3A1009D941A5F87D CRC64;
     MEAAAQFFVE SPDVVYGPEA IEAQYEYRTT RVSREGGVLK VHPTSTRFTF RTARQVPRLG
     VMLVGWGGNN GSTLTAAVLA NRLRLSWPTR SGRKEANYYG SLTQAGTVSL GLDAEGQEVF
     VPFSAVLPMV APNDLVFDGW DISSLNLAEA MRRAKVLDWG LQEQLWPHME ALRPRPSVYI
     PEFIAANQSA RADNLIPGSR AQQLEQIRRD IRDFRSSAGL DKVIVLWTAN TERFCEVIPG
     LNDTAENLLR TIELGLEVSP STLFAVASIL EGCAFLNGSP QNTLVPGALE LAWQHRVFVG
     GDDFKSGQTK VKSVLVDFLI GSGLKTMSIV SYNHLGNNDG ENLSAPLQFR SKEVSKSNVV
     DDMVQSNPVL YTPGEEPDHC VVIKYVPYVG DSKRALDEYT SELMLGGTNT LVLHNTCEDS
     LLAAPIMLDL ALLTELCQRV SFCTDMDPEP QTFHPVLSLL SFLFKAPLVP PGSPVVNALF
     RQRSCIENIL RACVGLPPQN HMLLEHKMER PGPSLKRVGP VAATYPMLNK KGPVPAATNG
     CTGDANGHLQ EEPPMPTT
//
